Shenzhen CPHI Expo in September: Focus on innovative resources of the pharmaceutical industry in the Greater Bay Area

On June 21, CPHI&PMEC China 2024 successfully concluded at the Shanghai New International Expo Center. The exhibition met expectations in terms of both scale and number of buyers, reaching new heights and was highly praised by exhibitors.

Following the Shanghai Expo, the 2024 Shenzhen Pharmaceutical Industry CPHI&PMEC Expo will be held at Shenzhen (Futian) Convention and Exhibition Center from September 9 to 11, becoming the next major event of common interest for global pharmaceutical industry elites to once again create the new growth pole of the pharmaceutical industry in the Greater Bay Area and Asia.

Pushing the boundaries and being at the forefront of pharmaceutical innovation

South China is one of the important gathering places for pharmaceutical enterprises. It has a huge pharmaceutical industry cluster and a driving force for innovation. It is an ideal area for the innovation, upgrading and development of the pharmaceutical industry. According to data from the National Bureau of Statistics, in recent years, the fixed asset investment in the pharmaceutical industry in South China has exceeded 1 trillion yuan, an increase of 5.9% year-on-year, which shows the strong vitality of the market.

In terms of geographical location, Shenzhen, as one of the important engines in southern China, has the advantage of resource exchange. Shenzhen is working hard to strengthen and promote the agglomeration of the pharmaceutical industry to create a hotspot for innovation in the pharmaceutical industry. It is estimated that by 2025, the total output value of Shenzhen’s biopharmaceutical industry is expected to exceed 200 billion yuan, indicating that the biopharmaceutical industry is growing rapidly in Shenzhen and is expected to become one of the important centers of my country’s biopharmaceutical industry.

The 2024CPHI Shenzhen exhibition will gather the resources of the core industries of the parent exhibition. The exhibits cover APIs and intermediates, biopharmaceuticals, preparations, pharmaceutical excipients, contract customization, natural extracts, preparation equipment, API equipment, packaging equipment, clean equipment and in the field. In the fields of engineering, laboratory construction and systems, the exhibition will deeply explore and release the potential of enterprises and inject new development momentum into the pharmaceutical industry.

Thanks to favorable policies, the storm of overseas purchases intensifies again

Statistics from the National Immigration Administration show that in the first half of the year, 14.635 million foreigners entered the country, a year-on-year increase of 152.7%. Among them, 8.542 million people entered the country without a visa, accounting for 52% and a year-on-year increase of 190.1%. The number of inbound tourists received in the four first-tier cities of Beijing, Shanghai, Guangzhou and Shenzhen has exceeded that of each quarter in 2023, rising to 67.2%, 64.0%, 53.2% and 83.0% respectively in the same period of 2019. It can be seen that Shenzhen is one of the cities that has most significantly resumed inbound tourism, showing strong growth momentum and recovery vitality.

At the same time, on May 21, Shenzhen issued the “Implementation Measures for Further Increasing the Attraction and Utilization of Foreign Investment”, which proposed to accelerate the international development of advanced manufacturing, build an international R&D innovation highland, and support foreign investment in the biomedical field and the acceleration of the modern service industry. Five measures, including opening up and expanding channels to attract foreign investment. The promulgation of this new policy fully demonstrates Shenzhen’s strategic intention to firmly promote opening up to the outside world and create a more favorable environment for foreign investment.

Taking this opportunity, the Shenzhen CPHI exhibition will also take advantage of the geographical advantages and policy support of the Guangdong-Hong Kong-Macao Greater Bay Area to actively strengthen ties with emerging markets in Asia, explore new opportunities for pharmaceutical trade and industrial chain integration, and create an environment for pharmaceutical companies. The second platform for international trade cooperation and exchanges outside the Shanghai exhibition.

Understanding the future trend and drawing a new model for the industry

During the exhibition, the organizers will also keep abreast of hot topics in the industry, gain insight into future development trends, and hold more than 10 forward-looking professional forums and seminars, covering topics such as the current status of the global pharmaceutical market, overseas enterprise strategies, peptides, synthetic biology, and intelligence. Manufacturing and other perspectives provide new ideas and solutions for the sustainable development of the pharmaceutical industry.

Some featured forums:

CPHI Shenzhen 2024 Conference on High-Quality Pharmaceutical Development

High-quality overseas seminar for CPHI pharmaceutical companies

Peptide Industry Innovation and Green Development Conference

The 2nd Greater Bay Area Pharmaceutical Manufacturing 4.0 Forum

Southeast Asia API Market Overview and Hot Topics Guidance Forum

Synthetic Biology Forum

Special laboratory forum

High Quality Development Forum for Solid Dosages